期刊
CELL AND BIOSCIENCE
卷 10, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s13578-020-00391-6
关键词
Telomere; Telomere maintenance mechanism; Alternative lengthening of telomeres (ALT); APBs; Phase separation; ALT telomeric DNA synthesis; RAD52; BLM; FANCM; Clinical therapy
资金
- MGH Cancer Center Excellence Award
To escape replicative senescence, cancer cells have to overcome telomere attrition during DNA replication. Most of cancers rely on telomerase to extend and maintain telomeres, but 4-11% of cancers use a homologous recombination-based pathway called alternative lengthening of telomeres (ALT). ALT is prevalent in cancers from the mesenchymal origin and usually associates with poor clinical outcome. Given its critical role in protecting telomeres and genomic integrity in tumor cells, ALT is an Achilles heel of tumors and an attractive target for cancer therapy. Here, we review the recent progress in the mechanistic studies of ALT, and discuss the emerging therapeutic strategies to target ALT-positive cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据